Literature DB >> 17458684

Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays.

C T Viswanathan1, Surendra Bansal, Brian Booth, Anthony J DeStefano, Mark J Rose, Jeffrey Sailstad, Vinod P Shah, Jerome P Skelly, Patrick G Swann, Russell Weiner.   

Abstract

The Third AAPS/FDA Bioanalytical Workshop, entitled "Quantitative Bioanalytical Methods Validation and Implementation: Best Practices for Chromatographic and Ligand Binding Assays" was held on May 1-3, 2006 in Arlington, VA. The format of this workshop consisted of presentations on bioanalytical topics, followed by discussion sessions where these topics could be debated, with the goal of reaching consensus, or identifying subjects where addition input or clarification was required. The discussion also addressed bioanalytical validation requirements of regulatory agencies, with the purpose of clarifying expectations for regulatory submissions. The proceedings from each day were reviewed and summarized in the evening sessions among the speakers and moderators of the day. The consensus summary was presented back to the workshop on the last day and was further debated. This communication represents the distillate of the workshop proceedings and provides the summary of consensus reached and also contains the validation topics where no consensus was reached.

Mesh:

Substances:

Year:  2007        PMID: 17458684     DOI: 10.1007/s11095-007-9291-7

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  3 in total

1.  Bioanalytical method validation--a revisit with a decade of progress.

Authors:  V P Shah; K K Midha; J W Findlay; H M Hill; J D Hulse; I J McGilveray; G McKay; K J Miller; R N Patnaik; M L Powell; A Tonelli; C T Viswanathan; A Yacobi
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

2.  Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules.

Authors:  Binodh DeSilva; Wendell Smith; Russell Weiner; Marian Kelley; JoMarie Smolec; Ben Lee; Masood Khan; Richard Tacey; Howard Hill; Abbie Celniker
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

3.  Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report.

Authors:  V P Shah; K K Midha; S Dighe; I J McGilveray; J P Skelly; A Yacobi; T Layloff; C T Viswanathan; C E Cook; R D McDowall
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Oct-Dec       Impact factor: 2.441

  3 in total
  140 in total

1.  Relative quantification of serum proteins from pancreatic ductal adenocarcinoma patients by stable isotope dilution liquid chromatography-mass spectrometry.

Authors:  Angela Y Wehr; Wei-Ting Hwang; Ian A Blair; Kenneth H Yu
Journal:  J Proteome Res       Date:  2012-02-15       Impact factor: 4.466

2.  Ligand binding assays in the 21st Century laboratory: platforms.

Authors:  Franklin P Spriggs; Zhandong Don Zhong; Afshin Safavi; Darshana Jani; Narasaiah Dontha; Anita Kant; Jenny Ly; Lia Brilando; Karolina Österlund; Nathalie Rouleau; Saloumeh Kadkhodayan Fischer; Martin Boissonneault; Chad Ray
Journal:  AAPS J       Date:  2012-03       Impact factor: 4.009

3.  Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspofungin.

Authors:  Laurent Arthur Decosterd; Bertrand Rochat; Benoît Pesse; Thomas Mercier; Frédéric Tissot; Nicolas Widmer; Jacques Bille; Thierry Calandra; Boris Zanolari; Oscar Marchetti
Journal:  Antimicrob Agents Chemother       Date:  2010-09-20       Impact factor: 5.191

4.  Nonclinical dose formulation analysis method validation and sample analysis.

Authors:  Monica Lee Whitmire; Peter Bryan; Teresa R Henry; John Holbrook; Paul Lehmann; Thomas Mollitor; Susan Ohorodnik; David Reed; Holly D Wietgrefe
Journal:  AAPS J       Date:  2010-08-14       Impact factor: 4.009

5.  Global metabolic profiling procedures for urine using UPLC-MS.

Authors:  Elizabeth J Want; Ian D Wilson; Helen Gika; Georgios Theodoridis; Robert S Plumb; John Shockcor; Elaine Holmes; Jeremy K Nicholson
Journal:  Nat Protoc       Date:  2010-06       Impact factor: 13.491

6.  Validation of an LC/MS method for the determination of gemfibrozil in human plasma and its application to a pharmacokinetic study.

Authors:  Joseph E Rower; Lane R Bushman; Kyle P Hammond; Rajendra S Kadam; Christina L Aquilante
Journal:  Biomed Chromatogr       Date:  2010-12       Impact factor: 1.902

7.  Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography-tandem mass spectrometry.

Authors:  Micol S Rothman; Nichole E Carlson; Mei Xu; Christina Wang; Ronald Swerdloff; Paul Lee; Victor H H Goh; E Chester Ridgway; Margaret E Wierman
Journal:  Steroids       Date:  2010-11-09       Impact factor: 2.668

8.  Use of pharmacokinetic data below lower limit of quantitation values.

Authors:  William J Jusko
Journal:  Pharm Res       Date:  2012-06-23       Impact factor: 4.200

9.  Standardization of Hemagglutination Inhibition Assay for Influenza Serology Allows for High Reproducibility between Laboratories.

Authors:  Mary Zacour; Brian J Ward; Angela Brewer; Patrick Tang; Guy Boivin; Yan Li; Michelle Warhuus; Shelly A McNeil; Jason J LeBlanc; Todd F Hatchette
Journal:  Clin Vaccine Immunol       Date:  2016-01-27

10.  Key elements of bioanalytical method validation for small molecules.

Authors:  Surendra Bansal; Anthony DeStefano
Journal:  AAPS J       Date:  2007-03-30       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.